Industry
Introducing GPT-Rosalind, our frontier reasoning model built to support research across biology, drug discovery, and translational medicine.
GPT-Rosalind is a frontier reasoning model developed by OpenAI, specifically designed to support research applications in biology, drug discovery, and translational medicine. The model was introduced
GPT-Rosalind is a frontier reasoning model developed by OpenAI, specifically designed to support research applications in biology, drug discovery, and translational medicine. The model was introduced by Sam Altman and represents OpenAI's effort to create specialized AI capabilities for scientific research in the life sciences domain.
Related
- OpenAI starts offering a biology-tuned LLM
- OpenAI partners with Novo Nordisk to accelerate drug discovery and delivery
- Introducing GPT-Rosalind for life sciences research
- Powering clinical research innovation: How TriNetX uses Databricks to accelerate drug development
Source: Sam Altman (X) | 2026-04-16